Home > Healthcare > Pharmaceuticals > Finished Drug Form > Precision Medicine Market
Precision Medicine Market Share
- Report ID: GMI671
- Published Date: Jun 2021
- Report Format: PDF
Precision Medicine Market Share
Some of the prominent players operating in the market include
- Pfizer Inc.
- Qiagen Inc.
- Quest Diagnostics Inc.
- Medtronic
- Novartis
- Laboratory Corporation of America Holdings
- bioMérieux SA
- Abbott Laboratories
- F. Hoffmann-La Roche AG
- Eli Lilly & Company
- Glaxosmithkline Plc.
- Cepheid Inc.
- AstraZeneca PLC
- Cancer Genetics Inc.
- Thermo Fisher Scientific Inc.
- Bristol-Myers Squibb
- Myriad Genetics Inc.
- Foundation Medicine
These industry leaders implementing various growth strategies to sustain industry competition and secure a substantial market position in the market.
Frequently Asked Questions (FAQ) :
The market for precision medicine was valued at around USD 52 billion in 2020 and will expand at a healthy CAGR of around 11.6% between 2021-2027.
The therapeutic segment will grow at a robust CAGR of around 10% through 2027 owing to the development of novel drugs and rising demand for drugs in precision medicine treatment plans.
Owing to increasing number of diagnostic centers and developments in diagnostic techniques, the segment is expected to expand at an impressive CAGR of 12% through 2027.
North America precision medicine market revenue was valued at 44% share in 2020 and will grow with the rising prevalence of genetic disorders and cancer.
Precision Medicine Market Scope
×
Get a free sample of
Precision Medicine Market
Inquiry Before Buying
Get special pricing options on this report
Request Sectional Data
Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours
below